July 29, 2014 11:44 PM ET

Healthcare Equipment and Supplies

Company Overview of Amaranth Medical, Inc.

Company Overview

Amaranth Medical, Inc. is a holding company operating through its subsidiary Amaranth Medical Pte Ltd. that develops biodegradable stents to treat peripheral vascular disease (PVD). The company was incorporated in 2006 and is based in Mountain View, California with an additional office in Singapore.

1145 Terra Bella Avenue

Suite A

Mountain View, CA 94043

United States

Founded in 2006

Phone:

650-965-3830

Fax:

650-325-4762

Key Executives for Amaranth Medical, Inc.

Chief Executive Officer
Founder and Director
Founder and Chief Scientific Officer
Compensation as of Fiscal Year 2014.

Amaranth Medical, Inc. Key Developments

Amaranth Medical Reports Positive Safety and Feasibility Findings for the FORTITUDE(TM) Bioresorbable Scaffold

Amaranth Medical presented positive six-month angiographic results from its first-in-human study including patients undergoing percutaneous coronary intervention (PCI) with single coronary lesions. The FORTITUDE(TM) non-drug eluting bioresorbable scaffold was successfully delivered in 12 patients within the target lesion. Post-deployment angiographic and IVUS analysis indicated that the FORTITUDE scaffold maintained its mechanical integrity, showing no indication of vessel recoil or other structural failures. At the time of the presentation, 10 patients had completed six-month angiographic follow up and six patients had available independent angiographic analysis indicating 0% binary restenosis. The data was presented at the "Next generation DES and bioabsorbable scaffolds" session at the Transcatheter Cardiovascular Therapeutics (TCT) meeting on October 27, 2013 in San Francisco, CA. Six-month angiographic follow-up data is available on 10 of the 13 patients enrolled in the first cohort and demonstrate excellent biomechanics and biocompatibility of the scaffolds. An independent core laboratory has reviewed findings on the first six patients, and affirmed that late lumen loss is similar to that observed with bare metal stents. Intravascular ultrasound and optical coherent tomography (OCT) images indicate that the scaffolds are fully opposed to the vessel walls with no indication of recoil or other compromise to their mechanical integrity.

Similar Private Companies By Industry

Company Name Region
Cormatrix Cardiovascular, Inc. United States
OrthoCor Medical, Inc. United States
Ellipse Technologies, Inc. United States
ETC BioMedical Systems Group United States
Biomet 3i LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
January 14, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Amaranth Medical, Inc., please visit www.amaranthmedical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.